| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.393 | 10.920 | 10.097 | 10.465 | 12.148 | 12.875 | 12.249 | 19.451 | 15.316 | 2.015 |
| Total Income - EUR | 10.510 | 10.953 | 10.115 | 10.523 | 12.240 | 12.875 | 12.249 | 19.451 | 15.316 | 2.015 |
| Total Expenses - EUR | 11.131 | 10.700 | 9.814 | 9.895 | 9.663 | 8.034 | 8.602 | 14.424 | 7.059 | 2.965 |
| Gross Profit/Loss - EUR | -621 | 252 | 301 | 629 | 2.577 | 4.841 | 3.647 | 5.027 | 8.257 | -950 |
| Net Profit/Loss - EUR | -937 | -76 | -2 | 313 | 2.210 | 4.454 | 3.324 | 4.451 | 7.081 | -950 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rx Comp Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 9 | 9 | 0 | 0 | 0 | 0 |
| Current Assets | 7.116 | 8.820 | 11.801 | 13.607 | 14.991 | 18.938 | 21.580 | 15.193 | 19.656 | 17.858 |
| Inventories | 4.335 | 6.746 | 9.064 | 9.752 | 9.202 | 10.302 | 10.117 | 10.108 | 10.065 | 10.009 |
| Receivables | 1.863 | 2.068 | 2.440 | 2.331 | 2.100 | 2.036 | 2.251 | 4.490 | 3.022 | 2.096 |
| Cash | 919 | 6 | 297 | 1.524 | 3.689 | 6.600 | 9.212 | 596 | 6.569 | 5.753 |
| Shareholders Funds | -4.007 | -4.043 | -3.977 | -3.591 | -1.311 | 3.168 | 6.421 | 4.500 | 9.188 | 8.187 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 11.124 | 12.862 | 15.777 | 17.197 | 16.311 | 15.779 | 15.158 | 10.693 | 10.468 | 9.679 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4651 - 4651" | |||||||||
| CAEN Financial Year |
4651
|
|||||||||
Comments - Rx Comp Srl